What a 42% rise in coupling-reagent prices does to a 15 mg vial
Follow the resin, not the catalogue.
Lucía Berenguer
Page 2 of 18 of this archive, newest first.
Archive — page 2
356 piecesWhat a 25% rise in coupling-reagent prices does to a 2 mg vial
Follow the resin, not the catalogue.
What changed at TFC in April, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What changed at Homopeptide in April, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What changed at QST in April, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Janoshik, Medutest, PeptideMeter, VendorInvestigate: a capability audit
The absence of microbiological capability in this market is a commercial fact with a straightforward explanation, and it is worth understanding before blaming anybody for it.
What changed at Homopeptide in April, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What a diode array adds, and why the certificate never shows it
Non-chromophoric components — counter-ions, salts, some excipients — contribute mass to the vial and nothing at all to the chromatogram.
What changed at SGN in April, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What a 30% rise in coupling-reagent prices does to a 15 mg vial
Follow the resin, not the catalogue.
What changed at TFC in April, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Two ways to lift a peptide into a vacuum, and why the answer differs
The ionisation method determines the charge states you see, the adducts you must account for, and the modifications you might destroy in the process.
What a 7% rise in coupling-reagent prices does to a 10 mg vial
Follow the resin, not the catalogue.
What changed at TFC in March, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What changed at GL Biochem in March, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What a 33% rise in coupling-reagent prices does to a 15 mg vial
Follow the resin, not the catalogue.
What a 31% rise in coupling-reagent prices does to a 2 mg vial
Follow the resin, not the catalogue.
What a 17% rise in coupling-reagent prices does to a 10 mg vial
Follow the resin, not the catalogue.
What a 32% rise in coupling-reagent prices does to a 10 mg vial
Follow the resin, not the catalogue.
What a 15% rise in coupling-reagent prices does to a 30 mg vial
Follow the resin, not the catalogue.